Tarceva – Erlotinib Tablet
ERLOTINIB (TARCEVA) INJECTION – TREATMENT FOR MULTIPLE CANCER
Erlotinib or Tarceva tablet is a cancer medicine that is used to treat non-small cell lung cancer and pancreatic cancer.
Tarceva tablet should be taken on an empty stomach or one hour before or two hours after a meal. You should take it for as long as your doctor recommends.
Non-small cell lung cancer is one of the most common types of lung cancer, affecting both smokers and nonsmokers. Tarceva 100mg TABLET is used to treat non-small cell lung cancer and can be taken alone or with additional medications. It is a potent and highly toxic medication, and you should consult your doctor about the risks and benefits. To stay hydrated, avoid consuming alcohol throughout this treatment and drink plenty of water.
USES OF ERLOTINIB (TARCEVA) INJECTION
- Non-small cell lung cancer
- Pancreatic cancer
WORKS OF ERLOTINIB (TARCEVA) INJECTION
Tarceva Tablet is a cancer treatment. Lung cancer cell surfaces express epidermal growth factor receptors (EGFR), which regulate cell growth. This medication works by binding the chemical messenger EGFR and thus inhibiting the cancer signaling pathways mediated by EGFR. This is how it prevents cancer cells from growing further.
SIDE EFFECTS OF ERLOTINIB (TARCEVA) INJECTION
The majority of adverse effects do not necessitate medical treatment and will go away as your body adjusts to the medication. Consult your doctor if they persist or if you are concerned.
- Abdominal pain
- Bone pain
- Muscle pain
WARNING & PRECAUTIONS
It is unknown whether Tarceva Tablet affects driving abilities. If you have any symptoms that impair your ability to concentrate or respond, do not drive.
Tarceva Tablet is not harmful to persons with kidney problems. Tarceva Tablet should not be dosed differently.
This medication is not recommended for those who have severe kidney disease.
In patients with liver problems, Tarceva Tablet should be used with caution. Tarceva Tablet dosage may need to be adjusted. Please consult your physician.
There is little information on the use of Tarceva Tablet in these patients. In patients with mild to severe liver disease, no dose change is indicated.
Fedelty Health Care is an Erlotinib third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.